Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Precigen
Biotech
New year, new name, new CEO for synthetic biology co. Intrexon
Two years after hiving off its healthcare assets into a subsidiary, Intrexon is bringing those assets back into the fold.
Amirah Al Idrus
Jan 3, 2020 10:38am
Ziopharm cuts Precigen ties, narrowing its R&D focus
Oct 10, 2018 11:05am
Change in direction at Intrexon has Germano heading for the exit
Mar 13, 2017 9:29am